Metastatic Uveal Melanoma Completed Phase 2 Trials for Pembrolizumab (DB09037)

Also known as: Metastatic Malignant Uveal Melanoma / Metastatic Uveal Melanoma (UM) / Uveal Melanoma, Metastatic / Melanoma, Uveal Metastatic

IndicationStatusPhase
DBCOND0051900 (Metastatic Uveal Melanoma)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02697630Efficacy Study of Pembrolizumab With Entinostat to Treat Metastatic Melanoma of the EyeTreatment